GB0426141D0 - Treatment - Google Patents

Treatment

Info

Publication number
GB0426141D0
GB0426141D0 GB0426141A GB0426141A GB0426141D0 GB 0426141 D0 GB0426141 D0 GB 0426141D0 GB 0426141 A GB0426141 A GB 0426141A GB 0426141 A GB0426141 A GB 0426141A GB 0426141 D0 GB0426141 D0 GB 0426141D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0426141A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Biomedica PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Biomedica PLC filed Critical UCL Biomedica PLC
Priority to GB0426141A priority Critical patent/GB0426141D0/en
Publication of GB0426141D0 publication Critical patent/GB0426141D0/en
Priority to ZA200704950A priority patent/ZA200704950B/en
Priority to SG200907712-4A priority patent/SG158073A1/en
Priority to PT05808837T priority patent/PT1824563E/en
Priority to DK10014283.5T priority patent/DK2319581T3/en
Priority to AT05808837T priority patent/ATE457187T1/en
Priority to EA200900105A priority patent/EA018007B1/en
Priority to SI200530993T priority patent/SI1824563T1/en
Priority to PT100142835T priority patent/PT2319581E/en
Priority to MX2007006171A priority patent/MX2007006171A/en
Priority to CN201110304561.7A priority patent/CN102512408B/en
Priority to CN2005800469901A priority patent/CN101102816B/en
Priority to NZ555870A priority patent/NZ555870A/en
Priority to PL05808837T priority patent/PL1824563T3/en
Priority to ES10014283.5T priority patent/ES2537974T3/en
Priority to PCT/GB2005/004539 priority patent/WO2006056794A1/en
Priority to EP09013613.6A priority patent/EP2153870B1/en
Priority to CA2589261A priority patent/CA2589261C/en
Priority to DK09013613.6T priority patent/DK2153870T3/en
Priority to DE602005019319T priority patent/DE602005019319D1/en
Priority to PL09013613T priority patent/PL2153870T3/en
Priority to EA200701146A priority patent/EA011716B1/en
Priority to DK05808837.8T priority patent/DK1824563T3/en
Priority to SI200531834T priority patent/SI2153870T1/en
Priority to EP05808837A priority patent/EP1824563B1/en
Priority to ES05808837T priority patent/ES2341120T3/en
Priority to PT90136136T priority patent/PT2153870E/en
Priority to ES09013613.6T priority patent/ES2448549T3/en
Priority to JP2007542118A priority patent/JP5116479B2/en
Priority to EP10014283.5A priority patent/EP2319581B1/en
Priority to PL10014283T priority patent/PL2319581T3/en
Priority to AU2005308622A priority patent/AU2005308622B2/en
Priority to KR1020077014477A priority patent/KR101380446B1/en
Priority to SI200531970T priority patent/SI2319581T1/en
Priority to US11/720,268 priority patent/US8389576B2/en
Priority to IL183401A priority patent/IL183401A/en
Priority to NO20073254A priority patent/NO342198B1/en
Priority to CY20101100397T priority patent/CY1112259T1/en
Priority to HK10107783.4A priority patent/HK1141471A1/en
Priority to US13/495,966 priority patent/US9566257B2/en
Priority to JP2012157179A priority patent/JP5612030B2/en
Priority to CY20141100215T priority patent/CY1114979T1/en
Priority to CY20151100464T priority patent/CY1116314T1/en
Priority to NO20161808A priority patent/NO341491B1/en
Priority to US15/430,233 priority patent/US10610506B2/en
Ceased legal-status Critical Current

Links

GB0426141A 2004-11-26 2004-11-26 Treatment Ceased GB0426141D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GB0426141A GB0426141D0 (en) 2004-11-26 2004-11-26 Treatment
SG200907712-4A SG158073A1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
DK05808837.8T DK1824563T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
EP05808837A EP1824563B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
PT05808837T PT1824563E (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
SI200531834T SI2153870T1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
AT05808837T ATE457187T1 (en) 2004-11-26 2005-11-28 COMPOSITIONS CONTAINING ORNITHINE AND PHENYL ACETATE OR PHENYLBUTYRATE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY
EA200900105A EA018007B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
SI200530993T SI1824563T1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
PT100142835T PT2319581E (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
MX2007006171A MX2007006171A (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy.
CN201110304561.7A CN102512408B (en) 2004-11-26 2005-11-28 Be used for the treatment of the compositions containing ornithine and phenylacetic acid or phenylbutyric acid of hepatic encephalopathy
CN2005800469901A CN101102816B (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
NZ555870A NZ555870A (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
PL05808837T PL1824563T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
ES10014283.5T ES2537974T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
PCT/GB2005/004539 WO2006056794A1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
EP09013613.6A EP2153870B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
CA2589261A CA2589261C (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
ES05808837T ES2341120T3 (en) 2004-11-26 2005-11-28 COMPOSITIONS THAT INCLUDE ORNITINE AND PHENYLACETATE OR PHENYLBUTIRATE TO TREAT HEPATIC ENCEPHALOPATHY.
DE602005019319T DE602005019319D1 (en) 2004-11-26 2005-11-28 COMPOSITIONS WITH ORNITHIN AND PHENYL ACETATE OR PHENYLBUTYRATE FOR THE TREATMENT OF HEPATIC ENZEPHALOPATHY
PL09013613T PL2153870T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
EA200701146A EA011716B1 (en) 2004-11-26 2005-11-28 Composition comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
ZA200704950A ZA200704950B (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalpathy
DK10014283.5T DK2319581T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate phenylbutyrate OR TREATMENT hepatic encephalopathy
US11/720,268 US8389576B2 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
DK09013613.6T DK2153870T3 (en) 2004-11-26 2005-11-28 COMPOSITIONS COMPRISING ornithine and phenylacetate phenylbutyrate OR TREATMENT hepatic encephalopathy
PT90136136T PT2153870E (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
ES09013613.6T ES2448549T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate to treat hepatic encephalopathy
JP2007542118A JP5116479B2 (en) 2004-11-26 2005-11-28 A composition for treating hepatic encephalopathy comprising ornithine and phenylacetate or phenylbutyrate
EP10014283.5A EP2319581B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
PL10014283T PL2319581T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
AU2005308622A AU2005308622B2 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
KR1020077014477A KR101380446B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
SI200531970T SI2319581T1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
IL183401A IL183401A (en) 2004-11-26 2007-05-24 Use of ornithine and ornithine with at least one of phenylacetate and phenylbutyrate in the manufacture of products and compositions containing them for use in preventing or treating liver decompensation or hepatic encephalopathy
NO20073254A NO342198B1 (en) 2004-11-26 2007-06-25 Compositions comprising ornithine and phenylacetate or phenylbutyrate to treat hepatic encephalopathy
CY20101100397T CY1112259T1 (en) 2004-11-26 2010-05-07 COMPOSITIONS THAT INCLUDE ORNITHINE AND PHENYLUXIC OR PHENYLUBUTURYSIS FOR TREATMENT OF US HEALTHCARE
HK10107783.4A HK1141471A1 (en) 2004-11-26 2010-08-16 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US13/495,966 US9566257B2 (en) 2004-11-26 2012-06-13 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
JP2012157179A JP5612030B2 (en) 2004-11-26 2012-07-13 A composition for treating hepatic encephalopathy comprising ornithine and phenylacetate or phenylbutyrate
CY20141100215T CY1114979T1 (en) 2004-11-26 2014-03-18 COMPOSITIONS THAT INCLUDE ORNITHINE AND PHENYLUXIC OR PHENYLUBUTURIC FOR USE HEALTHCARE HEALTH
CY20151100464T CY1116314T1 (en) 2004-11-26 2015-05-25 COMPOSITIONS CONTAINING ORNITHINE AND ACETIC PAIN OR BUTTERY PAIN FOR THE Treatment of US Cerebral Palsy
NO20161808A NO341491B1 (en) 2004-11-26 2016-11-16 Compositions comprising ornithine and phenylacetate or phenylbutyrate to treat hepatic encephalopathy
US15/430,233 US10610506B2 (en) 2004-11-26 2017-02-10 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0426141A GB0426141D0 (en) 2004-11-26 2004-11-26 Treatment

Publications (1)

Publication Number Publication Date
GB0426141D0 true GB0426141D0 (en) 2004-12-29

Family

ID=33561495

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0426141A Ceased GB0426141D0 (en) 2004-11-26 2004-11-26 Treatment

Country Status (3)

Country Link
CN (1) CN101102816B (en)
GB (1) GB0426141D0 (en)
ZA (1) ZA200704950B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007006171A (en) 2004-11-26 2007-10-08 Ucl Business Plc Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy.
NZ619235A (en) 2009-04-03 2015-06-26 Ocera Therapeutics Inc L-ornithine phenyl acetate and methods of making thereof
EP3517110A1 (en) 2009-06-08 2019-07-31 UCL Business PLC Treatment of inflammation using l-ornithine phenylacetate
BR112017010761B1 (en) 2014-11-24 2022-10-18 Ucl Business Plc TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STARTED CELL ACTIVATION WITH THE USE OF AMMONIA REDUCTION THERAPIES
WO2017031131A1 (en) 2015-08-18 2017-02-23 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
KR20180086431A (en) * 2015-11-13 2018-07-31 오세라 테라퓨틱스, 아이엔씨. Preparation of L-ornithine phenylacetate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
CN1383815A (en) * 2002-05-08 2002-12-11 刘万忠 Compound prepn of ornithine and asparagic acid for preventing and treating hepatosis and hepatic encephalopathy and its prepn process

Also Published As

Publication number Publication date
CN101102816A (en) 2008-01-09
CN101102816B (en) 2011-12-07
ZA200704950B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
GB0412070D0 (en) Treatment device
IL178616A0 (en) Wastewater treatment
IL186408A0 (en) Combination treatment methods
HK1075423A1 (en) Human nosecock
IL177155A0 (en) Therapeutic combinations
GB0417481D0 (en) Combination therapy
GB2430002B (en) Well treatment
GB0428180D0 (en) Combination therapy
GB0516068D0 (en) Well treatment
EP1809276A4 (en) Treatment method
GB0525540D0 (en) New treatment
GB0511769D0 (en) Treatment
GB0428187D0 (en) Cancer treatment
GB0424339D0 (en) Combination therapy
GB0424663D0 (en) Sludge treatment
GB0502171D0 (en) Well treatment
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
GB0701549D0 (en) Skin treatment
GB0425854D0 (en) Therapeutic treatment
GB0404675D0 (en) Cancer treatment
GB2412585B (en) Muscle treatment
GB0412411D0 (en) Treatment
GB0413584D0 (en) Well treatment
GB0421436D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)